Glycolipid and ganglioside metabolism imbalances in Huntington's disease. - Wikidata - awgldk - TriplyDB

Glycolipid and ganglioside metabolism imbalances in Huntington's disease.

Glycolipid and ganglioside metabolism imbalances in Huntington's disease.

http://www.wikidata.org/entity/Q36151607

about

Mouse models of polyglutamine diseases: review and data table. Part I Amyloid oligomer neurotoxicity, calcium dysregulation, and lipid rafts Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice Brain pathology in Niemann Pick disease type A: insights from the acid sphingomyelinase knockout mice Transcription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspective Increased Expression of Simple Ganglioside Species GM2 and GM3 Detected by MALDI Imaging Mass Spectrometry in a Combined Rat Model of Aβ Toxicity and Stroke Evidence for disruption of sphingolipid metabolism in schizophrenia.Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma.Integration of targeted metabolomics and transcriptomics identifies deregulation of phosphatidylcholine metabolism in Huntington's disease peripheral blood samples The role of glycosphingolipid metabolism in the developing brain.Functional roles of gangliosides in neurodevelopment: an overview of recent advances.Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction.Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction.Direct analysis of sialylated or sulfated glycosphingolipids and other polar and neutral lipids using TLC-MS interfaces.Sterols and sphingolipids: dynamic duo or partners in crime?Sphingolipids and brain resident macrophages in neuroinflammation: an emerging aspect of nervous system pathology.Lipid rafts in neurodegeneration and neuroprotection.Pathogenic role of ganglioside metabolism in neurodegenerative diseases.Nuclear Lipids in the Nervous System: What they do in Health and Disease.Lipid glycosylation: a primer for histochemists and cell biologists.Crosstalk between sphingolipids and vitamin D3: potential role in the nervous system.Impaired Levels of Gangliosides in the Corpus Callosum of Huntington Disease Animal Models Identifying therapeutic targets by combining transcriptional data with ordinal clinical measurements.Mitochondrial modulators improve lipid composition and attenuate memory deficits in experimental model of Huntington's disease.Early pridopidine treatment improves behavioral and transcriptional deficits in YAC128 Huntington disease mice.Age-dependent and regional heterogeneity in the long-chain base of A-series gangliosides observed in the rat brain using MALDI Imaging.Glyco-sphingo biology: a novel perspective for potential new treatments in Huntington's disease.Disease-modifying effects of ganglioside GM1 in Huntington's disease models.De novo Synthesis of Sphingolipids Is Defective in Experimental Models of Huntington's Disease.A novel relationship for schizophrenia, bipolar and major depressive disorder Part 3: Evidence from chromosome 3 high density association screen.Profiling and sequencing of gangliosides from human caudate nucleus by chip-nanoelectrospray mass spectrometry.Deficiency of ganglioside GM1 correlates with Parkinson's disease in mice and humans.Layer-specific lipid signatures in the human subventricular zone demonstrated by imaging mass spectrometry.Sphingomyelin and GM1 Influence Huntingtin Binding to, Disruption of, and Aggregation on Lipid Membranes.Estrogen Interactions With Lipid Rafts Related to Neuroprotection. Impact of Brain Ageing and Menopause.Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson's Disease.Regenerative Approaches in Huntington's Disease: From Mechanistic Insights to Therapeutic Protocols

P2860

Q26853025-25210958-0CF4-446F-9C9D-0E082624806D Q28742804-866FE7B3-228F-4FE7-ACDC-A81E985B8DEC Q30506469-CCC9FF24-DC5D-4AC4-9C19-8AA34C3784F5 Q34685652-D48E174F-CC3F-4C31-8B6E-451078A00786 Q35024695-FE7C7F47-544D-4961-A242-9A6D464B0605 Q35666915-ADEB1347-37AA-46D5-9278-53555F3DECA6 Q37023186-E0FFE5E3-C985-4F5F-A29B-9582923854A9 Q37130046-4DCBC29C-D875-445C-B72C-6583FEE2EE13 Q37131903-59BC424F-E6B7-43B2-B120-5973CDDE6B72 Q37290767-4EFA3F7C-A6C2-4118-9D56-A9A96855BBBC Q37494316-4FDA99D9-CC2E-403E-BDE4-8D88C6F9C446 Q37535345-64F271AC-F293-428C-A422-F026D384316F Q37652733-0B0722E4-88FD-412E-8B2D-E3F1C5EDF96E Q37665495-2036296F-C710-4411-B01D-785642D03BD2 Q37723587-45040391-5ADD-4EA1-B3E8-8FF5C6CDC944 Q38147080-38C8A294-C61D-420B-BC35-18AEFC37F32E Q38173298-9EE537E8-2F42-4F1D-A195-C6973C7A90C7 Q38218040-271D1991-1C13-4402-BA6E-710CA8DA38F6 Q38986890-405985FD-E831-414E-9CBB-72E076AF1C37 Q39045114-1BD285D8-409F-4ABC-A0D4-B744972E47FC Q39106107-6E94BCD0-2521-49A0-8F16-47E3F61CCDE8 Q41340916-9BB5949F-ADB2-43B4-BDE3-2796FFE437CE Q41701052-2FD00DDF-34BA-4D0C-B2D1-782E73D2C209 Q45290056-64437EC1-FB2F-4AFB-A80F-777F9C2DFB08 Q45305901-308997CC-E5B2-4121-95AA-6ACE1748290A Q46255046-3318FA27-3DA0-4127-B2F8-B9C24DC33A74 Q47098894-9D0041F8-F799-4373-982F-4498A231A02C Q47154575-3C03BA51-496A-4F91-A145-252BF4600129 Q47273613-B17F6481-D452-493F-A859-23A36584D949 Q47782721-FA43820D-03C8-4630-BA1C-BF65B6FC89CB Q48229884-1E63E3E7-54F8-4124-8A34-208C310B8495 Q48466996-3A220DEA-3C0A-4D63-9FD3-EF03D08864A0 Q49295184-6979F8D7-17EE-4983-A636-8496E32E7675 Q49331880-4C0C266D-DEEC-426E-A543-C4923F0D66EA Q51737507-D2618125-7D22-4413-9821-3E88722916C5 Q55412876-02FAEBCB-5622-448B-9DD4-4CE349A80AE3 Q59132159-55ACE2D7-E44E-4740-BA77-312EF6E84E60

P2860

Glycolipid and ganglioside metabolism imbalances in Huntington's disease.

http://www.wikidata.org/entity/Q36151607

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Glycolipid and ganglioside metabolism imbalances in Huntington's disease.

@ast

Glycolipid and ganglioside metabolism imbalances in Huntington's disease.

@en

type

label

Glycolipid and ganglioside metabolism imbalances in Huntington's disease.

@ast

Glycolipid and ganglioside metabolism imbalances in Huntington's disease.

@en

prefLabel

Glycolipid and ganglioside metabolism imbalances in Huntington's disease.

@ast

Glycolipid and ganglioside metabolism imbalances in Huntington's disease.

@en

P1433

Q36151607-76C8A956-DFF0-4802-853B-4DD706080BDB

P1476

Q36151607-EDA50862-1394-4417-A47F-45913B8A2219

P2093

Q36151607-44579D0C-9DDF-4A17-AB6C-0677808D8C80

Q36151607-7042D5E4-5C8F-4AFB-A71D-27195C78EA43

Q36151607-C0EF6370-BFA6-470E-8F1F-86654490EF8A

Q36151607-C4C857E7-97FA-43A2-ADA7-815241425A69

Q36151607-F305144C-21CA-45B1-8F88-8CD1F051E048

P2860

Q36151607-0476B5B0-6BFF-457C-BCB2-2FF02E348548

Q36151607-04C807C7-4A11-4A7E-8967-70CED99E8531

Q36151607-07BDF8F8-DB12-4020-9FF9-D5B455895E74

Q36151607-08B041CB-2D55-4CFB-8AB4-E73E9B191DF4

Q36151607-0C5A3BEE-EF89-4B98-8427-6877D7EF7260

Q36151607-13196DCA-73CB-496F-B194-A4F66826C074

Q36151607-1F390CF8-9E62-4C38-B106-38E21728BE22

Q36151607-1F6F905D-A394-4627-BBAD-178EE82FD066

Q36151607-204C0BED-5922-45A6-947E-226AAC2C17DA

Q36151607-2083DC68-1B78-4398-B9F9-1A8B7A9ADD75

P304

Q36151607-85A30AAC-33F3-4B0F-A74F-EDC69C75EC0D

P31

Q36151607-976DCF9B-C280-4522-A07B-1A660367946F

P356

Q36151607-4CB191F6-1016-4055-B827-0797A74218EC

P433

Q36151607-41A025DE-E580-4A89-A614-8FE8680D1699

P478

Q36151607-F116C415-B35A-4DC5-B265-F6BA74670934

P50

Q36151607-54593C41-CFBC-4E61-8322-F696AC094114

Q36151607-5D3820A0-A102-488F-86D3-42053A4AD59C

Q36151607-F943C05E-8D55-4205-B88F-6EAA0F5B8BC7

P577

Q36151607-9717F971-E844-40F9-976D-F19E6521FA22

P5875

Q36151607-0EA0B7BE-61E4-4196-8FB8-31909404CA71

P698

Q36151607-1D159353-AA01-4D25-A69D-F9960827015F

P921

Q36151607-94512F92-F8E6-4397-95E8-6D1794F9166E

P932

Q36151607-AC3CCF6B-CD00-44BD-A40B-01E780DB8811

P356

J.NBD.2007.05.003

P1433

Neurobiology of Disease

P1476

Glycolipid and ganglioside metabolism imbalances in Huntington's disease

@en

P2093

Elizabeth A Thomas

http://www.w3.org/2001/XMLSchema#string

J Gregor Sutcliffe

http://www.w3.org/2001/XMLSchema#string

Kristi E Kass

http://www.w3.org/2001/XMLSchema#string

Steven R Head

http://www.w3.org/2001/XMLSchema#string

Tim Gilmartin

http://www.w3.org/2001/XMLSchema#string

P2860

Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons

Expression monitoring by hybridization to high-density oligonucleotide arrays

Summaries of Affymetrix GeneChip probe level data

Enzyme alterations and lipid storage in three variants of Tay-Sachs disease

Normal huntingtin function: an alternative approach to Huntington's disease

A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder

Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system

Molecular cloning of Sia alpha 2,3Gal beta 1,4GlcNAc alpha 2,8-sialyltransferase from mouse brain

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

Dysmyelinogenesis in animal model of GM1 gangliosidosis.

P304

265-277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NBD.2007.05.003

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Thomas N Seyfried

Christine A. Denny

P577

2007-05-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6236290

http://www.w3.org/2001/XMLSchema#string

P698

17600724

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

2082128

http://www.w3.org/2001/XMLSchema#string